Try our Advanced Search for more refined results
Searching dockets in Snell Wilmer x
Alert me of new activity
All Case Activity Alerts Include: Answers, Appeals, Complaints, Motions, Orders, Trial Notes
367 Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability | Idaho
Corporate Disclosure Statement by BioLife Plasma Services, L.P., Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals International, Inc. identifying Corporate Parent Takeda Pharmaceuticals International, Inc. for Takeda Pharmaceuticals International, Inc.; Corporate Parent BioLife Plasma Services, L.P. for BioLife Plasma Services, L.P.; Corporate Parent Takeda Pharmaceuticals America, Inc. for Takeda Pharmaceuticals America, Inc.; Corporate Parent TPC Holdings, Inc. for Takeda Pharmaceutical Company Limited. (Martens Miller, Tara)
Notice Of Removal
NOTICE OF REMOVAL by All Defendants from Seventh Judicial District, Bonneville County State of Idaho, case number CV10-26-1611.(Filing fee $405 receipt numberAIDDC-3121523.), filed by All Defendants. (Attachments: # 1 Civil Coversheet, # 2 Exhibit A- State Court Complaint, # 3 Exhibit B- State Court Docket and Summons, # 4 Affidavit Declaration of Counsel in Support of Removal, # 5 Exhibit 1 to Declaration of Counsel in Support of Notice of Removal)(Martens Miller, Tara)
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login
Email (NOTE: Free email domains not supported)
First Name
Last Name
Job Title
PLEASE NOTE: A verification email will be sent to your address before you can access your trial.
Password (at least 8 characters required)
Confirm Password
Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.You’ll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. Please see our Privacy Policy.